Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Leases (2019 - 2026)

Usana Health Sciences (USNA) has disclosed Leases for 5 consecutive years, with $21.2 million as the latest value for Q4 2024.

  • On a quarterly basis, Leases rose 19.84% to $21.2 million in Q4 2024 year-over-year; TTM through Dec 2024 was $21.2 million, a 19.84% increase, with the full-year FY2024 number at $21.2 million, up 19.84% from a year prior.
  • Leases was $21.2 million for Q4 2024 at Usana Health Sciences, up from $17.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $27.9 million in Q1 2021 to a low of $17.7 million in Q4 2023.
  • A 4-year average of $22.1 million and a median of $21.2 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: fell 15.94% in 2022, then rose 19.84% in 2024.
  • Usana Health Sciences' Leases stood at $27.9 million in 2021, then decreased by 28.45% to $20.0 million in 2022, then fell by 11.63% to $17.7 million in 2023, then grew by 19.84% to $21.2 million in 2024.
  • Per Business Quant, the three most recent readings for USNA's Leases are $21.2 million (Q4 2024), $17.7 million (Q4 2023), and $20.0 million (Q4 2022).